Aggressive Merkel Cell Carcinoma After Janus Kinase Inhibitor Ruxolitinib for Polycythemia Vera

Merkel cell carcinoma (MCC) is a rare neuroendocrine carcinoma of the skin. It is highly aggressive and represents the second most common cause of skin cancer-related death. Ruxolitinib is an orally administered selective inhibitor of Janus associated kinases1 and 2, which is used in the management...

Full description

Saved in:
Bibliographic Details
Published in:In Vivo
Main Authors: RASTRELLI, MARCO, FERRAZZI, BEATRICE, TROPEA, SAVERIA, COSTA, ALESSANDRA, FINOTTO, SILVIA, MARINO, DARIO, CAMPANA, LUCA, DEL FIORE, PAOLO, ROSSI, CARLO RICCARDO, ALAIBAC, MAURO
Format: Artigo
Language:Inglês
Published: International Institute of Anticancer Research 2019
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6754986/
https://ncbi.nlm.nih.gov/pubmed/31471421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11653
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items